Detalhe da pesquisa
1.
Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy.
Eur J Cancer
; 107: 142-152, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30576970
2.
The Clinical Utility of Cell-Free DNA Measurement in Differentiated Thyroid Cancer: A Systematic Review.
Front Oncol
; 8: 132, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29761074